At this year’s EphMRA annual conference (online, 15-17 June), Erik Holzinger will be involved in 4 sessions covering Forecasting and Data Analytics:
- Connecting the dots of your forecast through Decision influence modelling. Erik will convene a session discussing how to incorporate the views of multiple stakeholders when assessing the market potential of a new product.
- The importance of labels – calibration in demand assessment for label change research. Erik will convene a session looking at real-work calibration of a demand assessment to make a more realistic estimate of future market potential.
- US gross-to-net discounts and contracting trends. Erik will present the results of very recent US payer research and analysis and present a simple tool to estimate applicable gross-to-net contracting discounts for early-stage commercial assessments. This session is co-chaired with Fritz Meyer (Boehringer Ingelheim).
- Advanced Analytics: What does it mean for Commercial Pharma? The speaker will explain what it takes to successfully apply advanced analytics, present a pharma-relevant use case, and show how advanced analytics can work with market research to create new insights.
For more details on any of these topics, please contact erik.holzinger@groupH.com.
Erik co-leads EphMRA’s Forecasting Forum, which meets on a monthly basis to discuss topics of interest. Participation is open to EphMRA members. Please contact Bernadette Rogers, firstname.lastname@example.org for details. We want to hear from you!